Abstract
This article provides a brief review of the current available data concerning present treatment and potential new treatment advances for pediatric anxiety disorders, such as generalized anxiety disorder, separation anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. Disorder-specific treatment methods and innovations, particularly computer-assisted methods of delivery for cognitive behavioral therapy (CBT) will be reviewed. Additionally, the paper will discuss novel psychopharmacological compounds (e.g., d-cycloserine, riluzole, memantine, and anticonvulsant medications). Available evidence for the efficacy of novel medication strategies in adult studies and implications for their use in pediatrics will be discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 52-61 |
Number of pages | 10 |
Journal | Annals of the New York Academy of Sciences |
Volume | 1304 |
Issue number | 1 |
DOIs | |
State | Published - Nov 2013 |
Keywords
- Anxiety
- Cognitive behavioral therapy
- Pediatric
- Pharmacotherapy
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Neuroscience(all)
- History and Philosophy of Science